Third Rock Ventures
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- USA
Investment stages
- Series B
Industries
- Cybersecurity
- Fintech
- AI
About
Thirdrockventures is a venture Capital firm headquartered in Boston, MA. The firm focuses on investing in innovative BioTech and health tech companies. It is known for its commitment to fostering diversity and inclusion within the life sciences sector. Notable investments include Seaport Therapeutics, Clasp Therapeutics, Synnovation Therapeutics, and bluebird bio, which recently received FDA approval for its treatment for sickle cell disease.
Thirdrockventures is a venture Capital firm headquartered in Boston, MA. The firm focuses on investing in innovative BioTech and health tech companies. It is known for its commitment to fostering diversity and inclusion within the life sciences sector. Notable investments include Seaport Therapeutics, Clasp Therapeutics, Synnovation Therapeutics, and bluebird bio, which recently received FDA approval for its treatment for sickle cell disease.
Investment Thesis
They invest in therapeutics. They are a venture studio focused on company formation that translates bleedingedge science into medicines that transform patient lives.
Portfolio
Thomson Reuters
Blue J Legal
Everlaw
EverCommerce
Quod Financial
Contract Express
Casetext
ThoughtWorks
Axiom
LexisNexis